Potent CD4+ T Cell Responses Elicited by a Bicistronic HIV-1 DNA Vaccine Expressing gp120 and GM-CSF
Dan H. Barouch(Beth Israel Deaconess Medical Center), Norman L. Letvin(Beth Israel Deaconess Medical Center), Michelle A. Lifton(Beth Israel Deaconess Medical Center), John W. Shiver(IGM Biosciences (United States)), Marcelo J. Kuroda(Beth Israel Deaconess Medical Center), Shawn S. Jackson(Beth Israel Deaconess Medical Center), Klara Tenner‐Racz(Bernhard Nocht Institute for Tropical Medicine), Dan Freed(United States Military Academy), Jörn E. Schmitz(Beth Israel Deaconess Medical Center), Mary-Ellen Davies(United States Military Academy), Helen C. Perry(United States Military Academy), Paul Rácz(Bernhard Nocht Institute for Tropical Medicine), Sampa Santra(Beth Israel Deaconess Medical Center)
Cited by 155
Related Papers
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein
|Science|1993|2.3k
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
|Nature|2002|1.2k
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
|Science|2020|1.1k
DNA VACCINES
|Annual Review of Immunology|1997|987